depression

First Opinion By Kate G. Farber and Charles H. Kellner

Don’t call electroconvulsive therapy ‘shock therapy’

Health By Andrew Joseph

Magic mushroom ingredient offers hope for treating depression

Health By Leah Samuel

Hospitals scramble to offer mental health care for depressed physicians

Quick Take By Megan Thielking

Nutritional supplements boost mood in patients taking antidepressants

Quick Take By Leah Samuel

Suicide rates are rising steeply, especially among middle-aged whites

Health By Joseph P. Kahn — Boston Globe

Tracking the risks and rewards of transcranial magnetic stimulation

Health By Judith Graham

Psychiatric shock therapy, long controversial, may face fresh restrictions

Quick Take By Eric Boodman

The science of heartbreak: A loved one’s death boosts risk of cardiac arrhythmia

Business By Rebecca Robbins

FDA rejects bid to market antidepressant to treat foggy thinking

First Opinion By Patrick Skerrett

Depression screening for adults and adolescents has benefits, but don’t ignore the downsides

Business By Rebecca Robbins

This antidepressant may be no better than cheaper alternatives. But demand could soon soar

Business By Asher Mullard

Could a drug that tamps down inflammation lift the fog of depression?

In the Lab By Megan Thielking

Scientists seek fast-acting antidepressant, from ketamine to laughing gas

Lab Chat By Megan Thielking

Lab Chat: Tailoring depression treatment using a blood test

Gut Check By Sharon Begley

Christmas suicide surge is a myth, but what about the January rebound?

Gut Check By Sharon Begley

Do antidepressants during pregnancy increase baby’s autism risk?

First Opinion By Frances Southwick

‘A painful facade’: My battle with depression as a medical resident